Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope?

E. M. Posadas, F. Simpkins, L. A. Liotta, C. MacDonald, E. C. Kohn

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Proteomics is an emerging field in medical science focused on the library of proteins specific to a given biosystem, the proteome, and understanding relationships therein. This field incorporates technologies that can be applied to serum and tissue in order to extract important biological information to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as a patient with cancer. These tools include laser capture microdissection, tissue lysate arrays and mass spectrometry approaches. These new technologies are more potent coupled with advanced bioinformatics analysis. They are used to characterize the content of, and changes in, the proteome induced by physiological changes, benign and pathologic. The application of these tools has assisted in the discovery of new biomarkers and may lead to new diagnostic tests and improvements in therapeutics. These tools additionally can provide a molecular characterization of cancers, which may allow for individualized molecular therapy. Understanding the basic concepts and tools used will illustrate how best to apply these technologies for patient benefit for the early detection of cancer and improved patient care.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
JournalAnnals of Oncology
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Proteomics
Proteome
Technology
Laser Capture Microdissection
Neoplasms
Systems Biology
Computational Biology
Early Detection of Cancer
Routine Diagnostic Tests
Mass Spectrometry
Patient Care
Therapeutics
Biomarkers
Serum
Proteins

Keywords

  • Cancer
  • Early detection
  • Laser capture microdissection
  • Proteomics
  • Surface-enhanced laser desorption ionization
  • Tissue lysate arrays

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Posadas, E. M., Simpkins, F., Liotta, L. A., MacDonald, C., & Kohn, E. C. (2005). Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope? Annals of Oncology, 16(1), 16-22. https://doi.org/10.1093/annonc/mdi004

Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope? / Posadas, E. M.; Simpkins, F.; Liotta, L. A.; MacDonald, C.; Kohn, E. C.

In: Annals of Oncology, Vol. 16, No. 1, 01.01.2005, p. 16-22.

Research output: Contribution to journalArticle

Posadas, EM, Simpkins, F, Liotta, LA, MacDonald, C & Kohn, EC 2005, 'Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope?', Annals of Oncology, vol. 16, no. 1, pp. 16-22. https://doi.org/10.1093/annonc/mdi004
Posadas, E. M. ; Simpkins, F. ; Liotta, L. A. ; MacDonald, C. ; Kohn, E. C. / Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope?. In: Annals of Oncology. 2005 ; Vol. 16, No. 1. pp. 16-22.
@article{5f2a918cca2f4a0e9f0cacd1e2a3f5fe,
title = "Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope?",
abstract = "Proteomics is an emerging field in medical science focused on the library of proteins specific to a given biosystem, the proteome, and understanding relationships therein. This field incorporates technologies that can be applied to serum and tissue in order to extract important biological information to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as a patient with cancer. These tools include laser capture microdissection, tissue lysate arrays and mass spectrometry approaches. These new technologies are more potent coupled with advanced bioinformatics analysis. They are used to characterize the content of, and changes in, the proteome induced by physiological changes, benign and pathologic. The application of these tools has assisted in the discovery of new biomarkers and may lead to new diagnostic tests and improvements in therapeutics. These tools additionally can provide a molecular characterization of cancers, which may allow for individualized molecular therapy. Understanding the basic concepts and tools used will illustrate how best to apply these technologies for patient benefit for the early detection of cancer and improved patient care.",
keywords = "Cancer, Early detection, Laser capture microdissection, Proteomics, Surface-enhanced laser desorption ionization, Tissue lysate arrays",
author = "Posadas, {E. M.} and F. Simpkins and Liotta, {L. A.} and C. MacDonald and Kohn, {E. C.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1093/annonc/mdi004",
language = "English",
volume = "16",
pages = "16--22",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Proteomic analysis for the early detection and rational treatment of cancer - Realistic hope?

AU - Posadas, E. M.

AU - Simpkins, F.

AU - Liotta, L. A.

AU - MacDonald, C.

AU - Kohn, E. C.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Proteomics is an emerging field in medical science focused on the library of proteins specific to a given biosystem, the proteome, and understanding relationships therein. This field incorporates technologies that can be applied to serum and tissue in order to extract important biological information to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as a patient with cancer. These tools include laser capture microdissection, tissue lysate arrays and mass spectrometry approaches. These new technologies are more potent coupled with advanced bioinformatics analysis. They are used to characterize the content of, and changes in, the proteome induced by physiological changes, benign and pathologic. The application of these tools has assisted in the discovery of new biomarkers and may lead to new diagnostic tests and improvements in therapeutics. These tools additionally can provide a molecular characterization of cancers, which may allow for individualized molecular therapy. Understanding the basic concepts and tools used will illustrate how best to apply these technologies for patient benefit for the early detection of cancer and improved patient care.

AB - Proteomics is an emerging field in medical science focused on the library of proteins specific to a given biosystem, the proteome, and understanding relationships therein. This field incorporates technologies that can be applied to serum and tissue in order to extract important biological information to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as a patient with cancer. These tools include laser capture microdissection, tissue lysate arrays and mass spectrometry approaches. These new technologies are more potent coupled with advanced bioinformatics analysis. They are used to characterize the content of, and changes in, the proteome induced by physiological changes, benign and pathologic. The application of these tools has assisted in the discovery of new biomarkers and may lead to new diagnostic tests and improvements in therapeutics. These tools additionally can provide a molecular characterization of cancers, which may allow for individualized molecular therapy. Understanding the basic concepts and tools used will illustrate how best to apply these technologies for patient benefit for the early detection of cancer and improved patient care.

KW - Cancer

KW - Early detection

KW - Laser capture microdissection

KW - Proteomics

KW - Surface-enhanced laser desorption ionization

KW - Tissue lysate arrays

UR - http://www.scopus.com/inward/record.url?scp=12344289403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344289403&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdi004

DO - 10.1093/annonc/mdi004

M3 - Article

C2 - 15598930

AN - SCOPUS:12344289403

VL - 16

SP - 16

EP - 22

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -